Addiction News and Research

RSS

Women and men are more stressed about the 2009 holiday season than last year, finds new study

From family conflict to anxiety about not being able to buy gifts for everyone on their list, women and men are more stressed about the 2009 holiday season than last year, according to a new study commissioned by Breakthrough at Caron, a five-and-a-half day intensive wellness program designed for adults seeking to break unhealthy life patterns. Breakthrough at Caron is part of Caron Treatment Centers, a 52-year-old nonprofit addiction treatment center located in Pennsylvania.

4 Dec 2009

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval to begin selecting and gene testing subjects for a trial of a simple, safe and effective treatment for what the World Health Organisation has described as a global epidemic of unhealthy eating and obesity.

3 Dec 2009

Fruit flies are valid models for studying drug addiction in humans, says scientists

Fruit flies may seem like unlikely heroes in the battle against drug abuse, but new research suggests that these insects - already used to study dozens of human disease - could claim that role. Scientists are reporting that fruit flies can be used as a simpler and more convenient animal model for studying the effects of cocaine and other drugs of abuse on the brain.

3 Dec 2009

Waterpipe tobacco smoking as deadly as cigarette smoking

Smoking tobacco through a waterpipe exposes the user to the same toxicants - carbon monoxide and nicotine - as puffing on a cigarette, which could lead to nicotine addiction and heart disease, according to a study led by a Virginia Commonwealth University researcher published in the December issue of the American Journal of Preventive Medicine.

3 Dec 2009

New nursing guideline to enhance improved care for MMT clients

A pregnant woman walks into a hospital in early labour. She feels nauseated and achy; her contractions are 20 minutes apart. There is more to her story than meets the eye. She is on methadone maintenance therapy (MMT) and wasn't able to pick up her daily dose at the pharmacy this morning. Although her story may be hard to believe she is one of the estimated 17,000 clients in Ontario currently receiving MMT.

2 Dec 2009

USPTO issues Notice of Allowance for Titan Pharmaceuticals' Probuphine patent application

Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan’s United States patent application directed to the use of Probuphine for the treatment of opiate addiction.

1 Dec 2009

Alcohol consumption in pregnancy affects child behaviour in different ways: Study

A new study from Perth's Telethon Institute for Child Health Research has found evidence that the amount and timing of alcohol consumption in pregnancy affects child behaviour in different ways.

23 Nov 2009

California issues strict rules for health professionals with addiction problems

News outlets report on a variety of health issues at the state level including stricter rules for drug abusers in the health industry in California, an examination of the nation's first city-run universal health care plan in San Francisco, a cigarette tax in Florida, sex offenders and ex-convicts in nursing homes in Illinois and efforts to battle medical errors in New Jersey.

20 Nov 2009

Study shows 'scale of craving' and previous heroin abuse are factors in people falling back into cocaine habit

Drug dependency is a recurrent but treatable kind of addiction. However, not all people who are drug dependent progress in the same way once they stop taking drugs. A new study shows that, in the case of cocaine, a high score on the so-called 'scale of craving', an antisocial personality type and previous heroin abuse are the factors most commonly involved in people falling back into the habit.

20 Nov 2009

Finding disproves clinical guidelines about dieting while quitting smoking

Many women don't quit smoking because they are afraid of gaining weight. That's because nicotine suppresses the appetite and boosts a smoker's metabolism.

20 Nov 2009

'Model' tobacco cessation program reduces smoking rate by 26%

A "model" tobacco cessation benefit offered to Massachusetts' Medicaid participants has produced an astounding 26% drop in smoking rates in only two and a half years, and has already been linked to decreases in heart attacks, hospitalizations for asthma and COPD, and a significant decrease in birth complications.

19 Nov 2009

Binge drinking, cannabis and prescription drugs still remain a concern among teenagers

While fewer teens are drinking alcohol in 2009 than a decade ago, binge drinking, use of cannabis and prescription drugs remain a concern, according to the 2009 Ontario Student Drug Use and Health Survey (OSDUHS) released today by the Centre for Addiction and Mental Health.

19 Nov 2009

Pfizer Canada accepts Prix Galien Canada 2009 Innovative Product Award for CHAMPIX

Pfizer Canada accepted the Prix Galien Canada 2009 Innovative Product Award for CHAMPIX (varenicline tartrate), the first prescription treatment for smoking cessation in adults specifically designed to target nicotine addiction. The award was presented last night at a gala in Ottawa recognizing excellence in pharmaceutical research.

18 Nov 2009

CCSA to focus on role of treatment systems at Canada's Issues of Substance 2009 conference

The Canadian Centre on Substance Abuse (CCSA) today announced that it will open Issues of Substance (IOS) 2009, Canada's biennial conference on substance abuse, with a focus on the role of treatment systems. More than 13 sessions will examine the role of treatment from a variety of perspectives, including the Models of Care project in the UK, the National Treatment Strategy in Canada (NTS) and case study and research presentations reviewing the effectiveness of a variety of integrated programs in Canada.

16 Nov 2009

Ketamine use increasing faster than any other drug in the UK, shows research

The first ever large-scale, longitudinal study of ketamine users has been published online today in the journal Addiction. With Ketamine (K, Special K) use increasing faster than any other drug in the UK (British Crime Survey, 2008) this research showing the consequences of repeated ketamine use provides valuable information for users and addiction professionals alike.

16 Nov 2009

Chronic pain patients with depression three times more likely to receive opioid medications

Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research.

16 Nov 2009

In rural Kentucky, an unexpected take on the health debate

Frank Browning reports for Kaiser Health News on how the health reform debate is playing out in rural Kentucky. "From a strip-mined bluff at the edge of this famous mountain town you can see one of the most concentrated and diverse sets of medical facilities in rural America: a general hospital, a psychiatric hospital, a university-based rural health care center and clinics for primary care, cancer, urology, cardiology, addiction and ear-nose-and throat problems.

13 Nov 2009

First Edition: November 13, 2009

On this Friday the 13th, the headlines offer an array of health policy views -- from the possibility of including a Medicare payroll tax in health reform legislation to continuing analysis of the overhaul's winners and losers as well as the CDC's new estimate of the far-reach of the swine flu.

13 Nov 2009

ADS' Medics Suite satisfies the unique needs of New Hope Foundation

Dr. Comerford is the President and CEO of the New Hope Foundation, a non-profit corporation dedicated to the treatment of alcoholism, drug addiction and compulsive gambling. The Foundation provides state-of-the-art care, with the ongoing certification of the Commission on Accreditation of Rehabilitation Facilities (CARF).

13 Nov 2009

Abbott signs agreement to acquire global rights to PanGenetics BV's PG110

Abbott announced today a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF), expanding the company's pain care portfolio and leveraging its expertise in biologics. PG110 is a novel biologic in Phase I clinical trial development that targets NGF for the treatment of chronic pain.

13 Nov 2009

Addiction News and Research

Women and men are more stressed about the 2009 holiday season than last year, finds new study

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

Fruit flies are valid models for studying drug addiction in humans, says scientists

Waterpipe tobacco smoking as deadly as cigarette smoking

New nursing guideline to enhance improved care for MMT clients

USPTO issues Notice of Allowance for Titan Pharmaceuticals' Probuphine patent application

Alcohol consumption in pregnancy affects child behaviour in different ways: Study

California issues strict rules for health professionals with addiction problems

Study shows 'scale of craving' and previous heroin abuse are factors in people falling back into cocaine habit

Finding disproves clinical guidelines about dieting while quitting smoking

'Model' tobacco cessation program reduces smoking rate by 26%

Binge drinking, cannabis and prescription drugs still remain a concern among teenagers

Pfizer Canada accepts Prix Galien Canada 2009 Innovative Product Award for CHAMPIX

CCSA to focus on role of treatment systems at Canada's Issues of Substance 2009 conference

Ketamine use increasing faster than any other drug in the UK, shows research

Chronic pain patients with depression three times more likely to receive opioid medications

In rural Kentucky, an unexpected take on the health debate

First Edition: November 13, 2009

ADS' Medics Suite satisfies the unique needs of New Hope Foundation

Abbott signs agreement to acquire global rights to PanGenetics BV's PG110

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News